News in the Life Sciences Industry

SUZHOU, China, Feb. 3, 2019 /PRNewswire/ -- On February 1, 2019, GeneQuantum Healthcare of Suzhou and MITRO Biotech of Nanjing signed the "Strategic Cooperation Agreement on Next Generation Radionuclide Conjugates Development" in Nanjing. Dr. Gang Qin, President of GeneQuantum and Dr. Xinping... Read more ››

HONG KONG, Feb. 1, 2019 /PRNewswire/ -- I-Mab Biopharma (I-Mab), a China-based clinical stage biopharmaceutical company exclusively focused on the development of innovative biologics in immuno-oncology and autoimmune diseases, today announces that it has entered into a memorandum of understanding... Read more ››

SHANGHAI, Jan. 29, 2019 /PRNewswire/ -- China's leading one-stop healthcare ecosystem platform Ping An Health Medical Technology Company Limited ("Ping An Good Doctor", or the "Company", stock code: 01833.HK) has announced that it has stationed a "One-minute Clinic" at the Nanjing Siqiao Expressway... Read more ››

SUZHOU, China, Jan. 28, 2019 /PRNewswire/ -- CStone Pharmaceuticals (CStone) today announced that the National Medical Products Administration (NMPA) recently approved the clinical trial application (CTA) to start a Phase I clinical trial in China for BLU-554 (CS3008), an inhibitor of fibroblast... Read more ››

SUZHOU, China, Jan. 28, 2019 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality innovative medicines for the treatment of oncology, autoimmune and other major diseases, announced... Read more ››